Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Danone quiet on medical nutrition division sale reports

By Mark Astley+

Last updated on 13-Feb-2014 at 17:46 GMT2014-02-13T17:46:29Z

Image: Danone
Image: Danone

French dairy giant Danone has declined to comment on reports that it has drafted in JP Morgan to advise on potential suitors for its medical nutrition division.

Reuters, citing sources close to the alleged deal , reported earlier today that the Paris-based dairy manufacturer Danone is open to offers from industry rivals for its medical nutrition business.

Sources claim that the company has called on financial services provider JP Morgan to advise on potential buyers, adding that the division is likely to attract interest from the likes of Abbott Laboratories, Nestlé, Baxter, and Fresenius.

The business, which reported sales of €994m ($1.36bn) for the first nine months of 2013, could fetch more than €3bn ($4.1bn), the Reuters report added.

When approached, Danone refused the opportunity to confirm or deny the reports.

“We have no comment to make,” Danone spokeswoman Charlotte Pasternak told

"Pressure on healthcare spending"

Danone’s medical nutrition division manufactures products for those weakened by illness or chronic conditions. Its product portfolio includes liquid food for hospital patients unable to eat solids, food supplements for elderly people with failing appetites, and products for allergy sufferers.

In 2012, the division reported a slowdown in growth, which Danone attributed to “deteriorating conditions on some markets in Western Europe.” Results for the first nine months of 2013 were also impacted “by overall pressure on healthcare spending.”

Divesting its medical nutrition division would allow Danone to focus on its infant nutrition and fresh dairy products division, which have suffered recently as a result of declining consumption in Europe and reputational issues in Asia.

Earlier this week, Danone announced that it is set to increase its interest in Chinese dairy manufacturer Mengniu to almost 10% through an investment of  €486m ($660m).  

Through the deal, which see Danone's stake in Mengniu increase from 4.4% to 9% if approved, Danone hopes "to capture the high growth potential of the chilled dairy products market in China,"

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars